Novartis Ireland Limited

Lobbying Organisation Novartis Ireland Limited

Date published 19 Sep, 2025

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2025 to 31 Aug, 2025

Specific Details Launch of the Rare Disease National Strategy at Department of Health

Intended results Advocate for Life Science Strategy and access to innovation

Name of person primarily responsible for lobbying on this activity Eibhlin Mulroe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Event / Reception (1)

Attended the Department of Health's (DOH) launch of the Rare Disease National Strategy. Made a comment from the floor about the need for a Life Science Strategy that speaks to the importance of valuing innovation.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Jennifer Carroll MacNeill Minister (Department of Health)